EDITORIAL
A magic bullet for gout?
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Correspondence to:
Correspondence to Professor A So, Department of Rheumatology, University Hospital Lausanne, 1011, Lausanne, Switzerland; alexanderkai-lik.so@chuv.ch
Accepted 22 July 2009
| The first 150 words of the full text of this article appear below. |
Do we need new treatments for gout? Hyperuricaemia, the metabolic condition underlying gouty inflammation, has attracted recent attention as new urate-lowering treatments emerge on the horizon. For an acute attack of gout, the currently available drugs—non-steroidal anti-inflammatory drugs, colchicine and corticosteroids, seem to do a pretty good job for the majority of patients in relieving the acute symptoms of inflammation. However, recent data have highlighted the epidemiological shifts in the gouty population towards a more elderly group of patients who often present multiple medical problems. This as well as clinical practice have made us aware that our current treatments of acute gout are not ideal in all situations. They may cause significant side effects in patients with poor renal and cardiac function, and practical experience indicates that quite a number of patients with chronic gout end up receiving long-term steroids, with all the side effects that such treatment engenders. Furthermore,
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Relevant Articles
- The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
- R Terkeltaub, J S Sundy, H R Schumacher, F Murphy, S Bookbinder, S Biedermann, R Wu, S Mellis, and A Radin
Ann Rheum Dis 2009 68: 1613-1617.[Abstract] [Full Text] [PDF]
- Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis
- R Torres, L Macdonald, S D Croll, J Reinhardt, A Dore, S Stevens, D M Hylton, J S Rudge, R Liu-Bryan, R A Terkeltaub, G D Yancopoulos, and A J Murphy
Ann Rheum Dis 2009 68: 1602-1608.[Abstract] [Full Text] [PDF]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Google Scholar
PubMed
Topic Collections
-
Genetics
-
Degenerative joint disease
-
Musculoskeletal syndromes
-
Immunology (including allergy)
-
Inflammation
- Relevant Articles
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
